3_Ghostwriting - Ross - GUEST AUTHORSHIP AND GHOSTWRITING...

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
egy of the companies was used to pro- mote and market the products. No stud- ies have used internal documents to characterize the role of authorship in collaborations between industry and the medical profession. Inc related to rofecoxib provided a unique opportunity to examine the practice of guest authorship and ghost- writing related to the research and pro- motion of this medication. Our objec- tive was to provide a review using a case-study exploration of court docu- ments, in tandem with a review of the medical literature, to describe the prac- tice of guest authorship and ghostwrit- ing related to rofecoxib. Documents used for this article are posted at http://dida.library.ucsf.edu. METHODS In the course of the combined trials of Cona vs Merck and Co, Inc (No. ATL- L-3553-05, New Jersey Superior Court, Atlantic City) and McDarby vs Merck and Co, Inc (No. ATL-L-1296-05, New Jersey Superior Court, Atlantic City), millions of documents were made avail- able to and archived in an integrated da- tabase maintained by the plaintiff’s at- torneys. These documents were created between 1996 and 2004 and included Merck internal and external correspon- dence, reports, and presentations. As consultants to attorneys on the behalf of plaintiffs, we had complete access to all archived documents. One investi- gator (J.S.R.) searched the database to extract a subset of documents related
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 10/10/2010 for the course ENG 000121 taught by Professor Mcgrand during the Spring '10 term at Cornell University (Engineering School).

Ask a homework question - tutors are online